Weihai Wego Biotechnology Co. Ltd.

Country/Region: China     State/Province: Shandong

Main Products: Autoclave Sterilizer

Company Introduction
Company ProfileWeigao Group Co., Ltd. is situated in the High-tech Industries Development Zone of Weihai City, a picturesque coastal open city. Weigao Group owns 30 subsidiaries, and has a total asset of 3.5 billion RMB. Shandong Weigao Group Medical Polymer Company Limited, as the biggest subsidiary company of the Group, became a public listed company at Growth Enterprise Market of Hong Kong in 2004. Of the total 10, 000 staff the group employs, 780 are honored with senior technical credentials. The group covers a manufacturing space of 1, 150, 000 square meters including clean room of 160, 000 square meters that meet GMP requirements. It produces more than 160 varieties of medical devices in more than 5, 000 specifications, including medical consumables, drug-coated heart stent, orthopedics implant materials, drugs , hemo purification series and medical facilities.Weihai Weigao Biotech Co. Ltd. is wholly-owned subsidiary to Weigao Group., mainly engaged in R&D, manufacturing and sales of dental materials, dental equipment and autoclave sterilizers, meanwhile dental zirconia blank and CAD/CAM system are the development focus. The company insist on the guideline of âpioneer, creation, practice, consolidationâ and strategy of âpeople oriented, technology advancedâ to promote continuous, rapid and health development.
Company Overview

Business Type: Exporter, Services

Year Established: 1998

Employees: Above 1000 People

Plant Area: 3,000-5,000 square meters

Contact Information

Fax: 86-631-5661021

Business Information

Main Markets: South America 11% Africa 10% Eastern Asia 8% Domestic Market 12% North America 8% Eastern Europe 11% Southern Europe 8% Mid East 11% Northern Europe 12% Oceania 9%

Trade Capacity: FOB, FCA, DDP

Contract Manufacturing: OEM Service Offered

Nearest Port: Weihai

Trade & Financial Information

Annual Revenue: Above US$100 Million

Total Revenue: Above US$100 Million

Export Revenue: US$10 Million - US$50 Million

Annual Output: Above US$100 Million

Registered Capital: US$1 Million - US$2.5 Million

Export Percentage: 81% - 90%

Payment Modes: USD, EUR, CHF

Lead Time: 18 days

Import/Export Mode: Have Own Export License

Product Showcase
Autoclave Sterilizer

CL-Link > Health & Medicines in China Health & Medicines in Shandong Sterilization Equipments in China Sterilization Equipments in Shandong